{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:53:09Z","timestamp":1790736789406,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Allergan AG, Zurich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00404-019-05043-w","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T09:32:52Z","timestamp":1549013572000},"page":"993-1000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis"],"prefix":"10.1007","volume":"299","author":[{"given":"Inessa","family":"Diomande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian-Piero","family":"Ghisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoEllen","family":"Welter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias K.","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0467-0170","authenticated-orcid":false,"given":"Cornelia","family":"Betschart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"5043_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/archderm.1989.01670140108021","volume":"125","author":"M McKay","year":"1989","unstructured":"McKay M (1989) Vulvodynia: a multifactorial clinical problem. Arch Dermatol 125:256\u2013262","journal-title":"Arch Dermatol"},{"issue":"2","key":"5043_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/LGT.0000000000000190","volume":"20","author":"J Bornstein","year":"2016","unstructured":"Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, Coady D (2016) 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Low Genit Tract Dis. 20(2):126\u2013130. \n                    https:\/\/doi.org\/10.1097\/LGT.0000000000000190","journal-title":"J Low Genit Tract Dis."},{"issue":"2","key":"5043_CR3","first-page":"82","volume":"58","author":"BL Harlow","year":"2003","unstructured":"Harlow BL, Stewart EG (2003) A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Women Assoc 58(2):82\u201388","journal-title":"J Am Med Women Assoc"},{"issue":"170","key":"5043_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2012.06.067","volume":"206","author":"BD Reed","year":"2012","unstructured":"Reed BD, Harlow SD, Sen A et al (2012) Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol 206(170):e1\u2013e9. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2011.08.012","journal-title":"Am J Obstet Gynecol"},{"key":"5043_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/IJWH.S37660","volume":"6","author":"LA Sadownik","year":"2014","unstructured":"Sadownik LA (2014) Etiology, diagnosis, and clinical management of vulvodynia. Int J Womens Health 6:437\u2013449. \n                    https:\/\/doi.org\/10.2147\/IJWH.S37660","journal-title":"Int J Womens Health"},{"issue":"1","key":"5043_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.lgt.0000225898.37090.04","volume":"11","author":"HK Haefner","year":"2007","unstructured":"Haefner HK (2007) Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia. J Low Genit Tract Dis 11(1):48\u201349","journal-title":"J Low Genit Tract Dis"},{"key":"5043_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1089\/jwh.2007.0677","volume":"17","author":"JT Sutton","year":"2008","unstructured":"Sutton JT, Bachmann GA, Arnold LD et al (2008) Assessment of vulvodynia symptoms in a sample of US women: a follow-up national incidence survey. J Womens Health 17:1285\u20131292. \n                    https:\/\/doi.org\/10.1089\/jwh.2007.0677","journal-title":"J Womens Health"},{"issue":"2","key":"5043_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/LGT.0000000000000021","volume":"18","author":"CK Stockdale","year":"2014","unstructured":"Stockdale CK, Lawson HW (2014) 2013 vulvodynia guideline update. J Low Genit Tract Dis. 18(2):93\u2013100. \n                    https:\/\/doi.org\/10.1097\/LGT.0000000000000021","journal-title":"J Low Genit Tract Dis."},{"issue":"6","key":"5043_CR9","doi-asserted-by":"publisher","first-page":"768.e1","DOI":"10.1016\/j.ajog.2016.07.037","volume":"215","author":"P Tommola","year":"2016","unstructured":"Tommola P, Unkila-Kallio L, Paetau A et al (2016) Immune activation enhances epithelial nerve growth in provoked vestibulodynia. Am J Obstet Gynecol 215(6):768.e1\u2013768.e8. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2016.07.037","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"5043_CR10","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","volume":"43","author":"KR Aoki","year":"2003","unstructured":"Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 43(Suppl 1):S9\u2013S15","journal-title":"Headache"},{"issue":"5","key":"5043_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP (2004) Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64(5):871\u2013875","journal-title":"Urology"},{"issue":"10","key":"5043_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00192-010-1162-9","volume":"21","author":"S Tirumuru","year":"2010","unstructured":"Tirumuru S, Al-Kurdi D, Latthe P (2010) Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome\/interstitial cystitis: a systematic review. Int Urogynecol J 21(10):1285\u20131300. \n                    https:\/\/doi.org\/10.1007\/s00192-010-1162-9","journal-title":"Int Urogynecol J"},{"key":"5043_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1526-4637.2003.03013.x","volume":"4","author":"B Jabbari","year":"2003","unstructured":"Jabbari B, Maher N, Difasio MP (2003) Botulinum toxin improved burning pain and allodynia in two patients with spinal cord pathology. Pain Med. 4:206\u2013210","journal-title":"Pain Med."},{"key":"5043_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000010198","volume":"48","author":"N Bohm-Starke","year":"1999","unstructured":"Bohm-Starke N, Hilliges M, Falconer C et al (1999) Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest. 48:270\u2013275","journal-title":"Gynecol Obstet Invest."},{"key":"5043_CR15","first-page":"572","volume":"91","author":"LV Westrom","year":"1998","unstructured":"Westrom LV, Willen R (1998) Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 91:572\u2013576","journal-title":"Obstet Gynecol"},{"key":"5043_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/sj.ijir.3901487","volume":"19","author":"H Yoon","year":"2007","unstructured":"Yoon H, Chung WS, Shim BS (2007) Botulinum toxin A for the management of vulvodynia. Int J Impot Res 19:84\u201387","journal-title":"Int J Impot Res"},{"key":"5043_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpain.2004.02.575","volume":"5","author":"J Gunter","year":"2004","unstructured":"Gunter J, Brewer A, Tawfik O (2004) Botulinum toxin A for vulvodynia: a case report. J Pain 5:238\u2013240","journal-title":"J Pain"},{"key":"5043_CR18","first-page":"467","volume":"51","author":"DD Dykstra","year":"2006","unstructured":"Dykstra DD, Presthus J (2006) Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study. J Reprod Med 51:467\u2013470","journal-title":"J Reprod Med"},{"key":"5043_CR19","first-page":"635","volume":"51","author":"CS Brown","year":"2006","unstructured":"Brown CS, Glazer HI, Vogt V et al (2006) Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med 51:635\u2013641","journal-title":"J Reprod Med"},{"issue":"9","key":"5043_CR20","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","volume":"6","author":"CD Petersen","year":"2009","unstructured":"Petersen CD, Giraldi A, Lundvall L et al (2009) Botulinum toxin type A\u2014a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 6(9):2523\u20132537. \n                    https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01378.x","journal-title":"J Sex Med."},{"key":"5043_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2133.2011.10235.x","volume":"164","author":"F Pelletier","year":"2011","unstructured":"Pelletier F, Parratte B, Penz S et al (2011) Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia. Br J Dermatol 164:617\u2013622. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10235.x","journal-title":"Br J Dermatol"},{"key":"5043_CR22","first-page":"110","volume":"32","author":"EGJ Friedrich","year":"1987","unstructured":"Friedrich EGJ (1987) Vulvar vestibulitis syndrome. J. Reprod. Med 32:110\u2013114","journal-title":"J. Reprod. Med"},{"issue":"Pt A","key":"5043_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.toxicon.2015.09.037","volume":"107","author":"OO Ojo","year":"2015","unstructured":"Ojo OO, Fernandez HH (2015) Is it time for flexibility in botulinum inter-injection intervals? Toxicon 107(Pt A):72\u201376. \n                    https:\/\/doi.org\/10.1016\/j.toxicon.2015.09.037","journal-title":"Toxicon"},{"issue":"2","key":"5043_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3959(01)00371-2","volume":"94","author":"MC Rowbotham","year":"2001","unstructured":"Rowbotham MC (2001) What is a \u201cclinically meaningful\u201d reduction in pain? Pain 94(2):131\u2013132","journal-title":"Pain"},{"issue":"1","key":"5043_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/LGT.0000000000000041","volume":"19","author":"RH Nguyen","year":"2015","unstructured":"Nguyen RH, Mathur C, Wynings EM et al (2015) Remission of vulvar pain among women with primary vulvodynia. Low Genit Tract Dis. 19(1):62\u201367. \n                    https:\/\/doi.org\/10.1097\/LGT.0000000000000041","journal-title":"Low Genit Tract Dis."},{"issue":"2","key":"5043_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/14034940210134040","volume":"31","author":"I Danielsson","year":"2003","unstructured":"Danielsson I, Sj\u00f6berg I, Stenlund H et al (2003) Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health 31(2):113\u2013118","journal-title":"Scand J Public Health"},{"issue":"3","key":"5043_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000079620","volume":"58","author":"S Romito","year":"2004","unstructured":"Romito S, Bottanelli M, Pellegrini M et al (2004) Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest 58(3):164\u2013167","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"5043_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1740774516663461","volume":"14","author":"CC Bachour","year":"2017","unstructured":"Bachour CC, Bachmann GA, Foster DC, Wan JY, Rawlinson LA, Brown CS (2017) Gabapentin Study Group (GABAgroup) Recruitment methods in a clinical trial of provoked vulvodynia: predictors of enrollment. Clinical Trials 14(1):103\u2013108. \n                    https:\/\/doi.org\/10.1177\/1740774516663461","journal-title":"Clinical Trials"},{"key":"5043_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12905-015-0265-3","volume":"15","author":"S Lindst\u00f6m","year":"2015","unstructured":"Lindst\u00f6m S, Kvist L (2015) Treatment of provoked vulvodynia in a Swedish cohort using desensitization exercises and cognitive behavioral therapy. BMC Women\u2019s Health 15:108. \n                    https:\/\/doi.org\/10.1186\/s12905-015-0265-3","journal-title":"BMC Women\u2019s Health"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05043-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05043-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05043-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:12:04Z","timestamp":1580497924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05043-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["5043"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05043-w","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"17 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Study design was approved by Ethics Commission of Zurich (KEK-ZH StV 16\/2005). All patients provided written consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The datasets used and\/or analyzed during this current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The drug botulinum toxin type A was provided free of charge by Allergan AG, Zurich, Switzerland. The role of Allergan AG was solely in provision of the medication. The company was not involved in the study design; data collection, analysis, or interpretation; writing of the report; or decision to submit the paper for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of funding support"}}]}}